SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
VVUS: VIVUS INC. (NASDAQ)
An SI Board Since September 1997
Posts SubjectMarks Bans Symbol
23519 69 0 VVUS
Emcee:  Frostman Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
23369Feuerstein on (Tweet) the subject this morning..... "FDA asked 4 this?&quscaram(o)uche-1/9/2012
23368>> but I feel that FDA should now solicit unrestricted NDA with REMS <&scaram(o)uche-1/9/2012
23367one-day meeting, free webcast....... fda.govscaram(o)uche-12/28/2011
23366hmmmmmm......... ok, that's the 3/11 label. The July revision reduced relatiscaram(o)uche-12/21/2011
23365fda.gov <i>ISSUE: FDA notified healthcare professionals and patients of ascaram(o)uche-12/21/2011
23364thanks rick.fred hayes-12/21/2011
23363The twitter twerps have it correct, the study showed that topiramate is likely ascaram(o)uche-12/21/2011
23362FORTRESS topline doesn't exactly look "clean", but my impression nfred hayes-12/21/2011
23361VIVUS Reports Topline Findings From FORTRESS MOUNTAIN VIEW, Calif. , Dec. 21, scaram(o)uche-12/21/2011
23360J Clin Neurosci. 2011 Nov 18. [Epub ahead of print] Teratogenicity of the newescaram(o)uche-12/1/2011
23359any op to float his [quite silly] hypothesis, and showing the vast knowledge of scaram(o)uche-11/17/2011
23358>> Sanderson? << Simos Simeonidisscaram(o)uche-11/14/2011
23357I should comment...... Message 27510113 While I believe that AF has gone bonkscaram(o)uche-11/11/2011
23356thestreet.com Adam doesn't pass up an op (emphasis mine), and "echo&quscaram(o)uche-11/11/2011
23355Don't know if this was his previous stance, but Cowen analyst (Sanderson?) ascaram(o)uche-11/8/2011
23354>> Rates of serious adverse events were the same across treatment groups. scaram(o)uche-11/3/2011
23353PDUFA, 4/17/12scaram(o)uche-11/3/2011
23352finance.yahoo.com Insight: Firms to charge smokers, obese more for healthcare scaram(o)uche-10/30/2011
23351Message 27649871 >> It doesn't make any sense, including ECONOMIC senscaram(o)uche-9/22/2011
23350The highly ethical Jonathon Aschoff, John Welsh and Adam Feuerstein are aligned scaram(o)uche-9/21/2011
23349Thanks, Jason. Tons of discussion/fear out there, centered around the comment scaram(o)uche-9/16/2011
23348GekkoWire's comment on this plan to refile, along with comments on the commetnsaf-9/16/2011
23347VIVUS Provides Regulatory Update on QNEXA Agreement Reached with FDA to Re-Subscaram(o)uche-9/15/2011
23346Pfizer wins..... Message 27569216scaram(o)uche-8/15/2011
23345Just noticed this thread, and then read a few posts. As some of you know, I am Biotech Jim-7/7/2011
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News